Articles: chronic.
-
Non-Invasive VentilationSESSION TYPE: Slide PresentationsPRESENTED ON: Saturday, March 22, 2014 at 12:15 PM - 01:15 PMPURPOSE: Evaluation of non invasive ventilation (NIV) instituted for the first time in hospitalizations of patients with exacerbation of chronic obstructive pulmonary disease (COPD) associated with acute hypercapnic respiratory failure (AHRF) and its prognosis. ⋯ The following authors have nothing to disclose: Maria João Oliveira, Margarida Dias, Inês Franco, Sara CondeNo Product/Research Disclosure Information.
-
Slide PresentationsPRESENTED ON: Monday, March 24, 2014 at 09:00 AM - 10:00 AMPURPOSE: Epidemiologic characterization of ICU admissions of patients with exacerbation of COPD, review and comparison of severity scores with the remaining ICU admissions and analysis of prognostic factors for mortality and complications. ⋯ The following authors have nothing to disclose: Ricardo Reis, Margarida Dias, Artur Vale, Francisco EstevesNo Product/Research Disclosure Information.
-
Slide PresentationsPRESENTED ON: Sunday, March 23, 2014 at 04:15 PM - 05:15 PMPURPOSE: The purpose of this study was to evaluated the effect of triple-combined long acting inhaled bronchodilator treatment with roflumilast and dual-combined long acting inhaled bronchodilator and single-long acting inhaled bronchodilator treatment on exacerbations in patients with severe and very severe chronic obstructive pulmonary disease(COPD). ⋯ The following authors have nothing to disclose: Alizamin Sadigov, Sakhavatdin Akhundov, Rovshan BagirovNo Product/Research Disclosure Information.
-
Symptoms of Respiratory Disease PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: FeNO (fractional exhaled nitric oxide) may help identify cases of NAEB (nonasthmatic eosinophilic bronchitis) or asthma. The aim of this study is to evaluate the utility of FeNO in the evaluation of chronic cough ⋯ The following authors have nothing to disclose: Vijo PouloseNo Product/Research Disclosure Information.
-
Comorbidities of OSA PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: To provide new insight into the expression of TLR2 and TLR4 from OSAHS. ⋯ The following authors have nothing to disclose: Junjun HuangNo Product/Research Disclosure Information.